Your browser doesn't support javascript.
loading
Transcriptional profiling upon T cell stimulation reveals down-regulation of inflammatory pathways in T and B cells in SLE versus Sjögren's syndrome.
Kwon, Gino; Wiedemann, Annika; Steinheuer, Lisa M; Stefanski, Ana-Luisa; Szelinski, Franziska; Racek, Tomas; Frei, Andreas Philipp; Hatje, Klas; Kam-Thong, Tony; Schubert, David; Schindler, Thomas; Dörner, Thomas; Thurley, Kevin.
Afiliação
  • Kwon G; Systems Biology of Inflammation, German Rheumatism Research Center, a Leibniz-Institute, Berlin, Germany.
  • Wiedemann A; Rheumatology and Clinical Immunology, Department of Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Steinheuer LM; Biomathematics Division, Institute of Experimental Oncology, University Hospital Bonn, Bonn, Germany.
  • Stefanski AL; Rheumatology and Clinical Immunology, Department of Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Szelinski F; Rheumatology and Clinical Immunology, Department of Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Racek T; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Frei AP; Roche Pharma Research and Early Development, Immunology, Infectious Diseases and Ophthalmology (I2O) Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Hatje K; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Kam-Thong T; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Schubert D; Roche Pharma Research and Early Development, Immunology, Infectious Diseases and Ophthalmology (I2O) Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Schindler T; Product Development Immunology, F. Hoffmann-La Roche AG, Basel, Switzerland.
  • Dörner T; Rheumatology and Clinical Immunology, Department of Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany. thomas.doerner@charite.de.
  • Thurley K; Systems Biology of Inflammation, German Rheumatism Research Center, a Leibniz-Institute, Berlin, Germany. kevin.thurley@uni-bonn.de.
NPJ Syst Biol Appl ; 9(1): 62, 2023 Dec 15.
Article em En | MEDLINE | ID: mdl-38102122
ABSTRACT
Systemic lupus erythematosus (SLE) and primary Sjögren's syndrome (pSS) share clinical as well as pathogenic similarities. Although previous studies suggest various abnormalities in different immune cell compartments, dedicated cell-type specific transcriptomic signatures are often masked by patient heterogeneity. Here, we performed transcriptional profiling of isolated CD4, CD8, CD16 and CD19 lymphocytes from pSS and SLE patients upon T cell stimulation, in addition to a steady-state condition directly after blood drawing, in total comprising 581 sequencing samples. T cell stimulation, which induced a pronounced inflammatory response in all four cell types, gave rise to substantial re-modulation of lymphocyte subsets in the two autoimmune diseases compared to healthy controls, far exceeding the transcriptomic differences detected at steady-state. In particular, we detected cell-type and disease-specific down-regulation of a range of pro-inflammatory cytokine and chemokine pathways. Such differences between SLE and pSS patients are instrumental for selective immune targeting by future therapies.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Síndrome de Sjogren / Lúpus Eritematoso Sistêmico Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Síndrome de Sjogren / Lúpus Eritematoso Sistêmico Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article